These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34842024)

  • 1. Superlatives in news articles reporting non-FDA approved indications for use of cannabis and cannabis products with a focus on psychiatric disorders: a cross-sectional analysis.
    Ottwell R; Wenger D; Tom J; Potter I; Wirtz A; Dunn K; Vassar M
    J Ment Health; 2022 Feb; 31(1):109-114. PubMed ID: 34842024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superlative use within news articles relating to therapies for multiple sclerosis.
    Ferrell M; Ferrell S; Ottwell R; Johnson J; Vassar M
    Mult Scler Relat Disord; 2021 Apr; 49():102736. PubMed ID: 33444956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of sensational language describing stem cell therapies in news articles: a cross-sectional analysis.
    Pham V; Slawson M; Nicks S; Ottwell R; Greiner B; Vassar M
    Regen Med; 2021 Oct; 16(10):909-913. PubMed ID: 34519221
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
    Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
    Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
    Oberbarnscheidt T; Miller NS
    J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Medicine: Cannabis and Cannabis-Related Drugs.
    Moss DA; Hawks MK; Snyder MJ; Crawford PF
    FP Essent; 2021 Jun; 505():28-34. PubMed ID: 34128629
    [No Abstract]   [Full Text] [Related]  

  • 8. A scoping review of the use of cannabidiol in psychiatric disorders.
    Kirkland AE; Fadus MC; Gruber SA; Gray KM; Wilens TE; Squeglia LM
    Psychiatry Res; 2022 Feb; 308():114347. PubMed ID: 34952255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol (CBD): Perspectives from Pinterest.
    Merten JW; Gordon BT; King JL; Pappas C
    Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current legal status of medical marijuana and cannabidiol in the United States.
    Alharbi YN
    Epilepsy Behav; 2020 Nov; 112():107452. PubMed ID: 32956945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 14. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
    Zenone MA; Snyder J; Crooks V
    BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
    Tran T; Kavuluru R
    Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.
    Leas EC; Moy N; McMenamin SB; Shi Y; Benmarhnia T; Stone MD; Trinidad DR; White M
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer.
    Opitz BJ; Ostroff ML; Whitman AC
    J Pharm Pract; 2020 Aug; 33(4):506-512. PubMed ID: 30776990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.